Autonomix Medical, Inc.
AMIX Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 23, 2026
$2.42
KIRA · Stoqly’s AI analyst, in plain words
- Autonomix Medical, Inc. had $0.0M of revenue in fiscal 2026.
- Autonomix Medical, Inc. lost $16.7M in fiscal 2026.
- Free cash flow was −$12.3M in fiscal 2026, — of revenue.
Market cap
—
P/E
—
Revenue
$0.0M
Net income
−$16.7M
Free cash flow
−$12.3M
Operating margin
—
Autonomix Medical, Inc. in 30 seconds · fiscal 2026
Does it make a profit?
−$16.7M
No. It lost money last year.
What Autonomix Medical, Inc. does
No business description yet.
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 10-K · May 27, 2026
- Legal name
- Autonomix Medical, Inc.
- CIK
- 0001617867
Autonomix Medical, Inc. · AMIX
Results and finances
The last 4 fiscal years. Amounts in USD.
| Fiscal year | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales and profit | ||||
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | −$2.0M | −$15.4M | −$11.4M | −$16.7M |
| Cash | ||||
| Cash from operations | −$1.9M | −$6.6M | −$8.3M | −$12.3M |
| Capital expenditure | $0.0M | $0.0M | $0.0M | $0.0M |
| Free cash flow | −$1.9M | −$6.6M | −$8.3M | −$12.3M |
| Debt and strength | ||||
| Cash and short-term investments | $0.9M | $8.6M | $9.1M | $7.0M |
| Debt incl. finance leases | $0.0M | $0.0M | — | — |
| Shareholders' equity | $0.6M | $7.6M | $8.1M | $5.9M |
| Current ratio | 3.9x | 12.1x | 5.6x | 4.4x |
| Interest coverage | — | −152.3x | −65.8x | — |
| Returns and quality | ||||
| Return on equity | −309.0% | −373.0% | −145.1% | −238.9% |
| Return on tangible equity | −309.0% | −202.2% | −140.9% | −283.5% |
| Piotroski F-score | — | 3 | — | — |
| Altman Z'' | −96.2 | −11.6 | −14.4 | −35.1 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Autonomix Medical, Inc. · AMIX
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $2.42 a share, the company is worth —.
Source: SEC EDGAR XBRL filings (CIK 0001617867). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.